Horizon Therapeutics Plc (HZNP)

26.34
0.09 0.34
NASDAQ : Health Technology
Prev Close 26.43
Open 26.42
Day Low/High 26.05 / 26.66
52 Wk Low/High 16.56 / 29.44
Volume 1.30M
Avg Volume 1.84M
Exchange NASDAQ
Shares Outstanding 186.45M
Market Cap 4.93B
EPS -0.50
P/E Ratio 68.05
Div & Yield N.A. (N.A)
Trade-Ideas: Horizon Pharma (HZNP) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Horizon Pharma (HZNP) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate

Horizon Pharma Inc Stock Downgraded (HZNP)

Horizon Pharma Inc Stock Downgraded (HZNP)

Horizon Pharma (Nasdaq:HZNP) has been downgraded by TheStreet Ratings from from a hold to sell.

Ratings Changes Today

Upgrades: AI, BBX, CALL, CLDT, GRA, HIL, PJC, SSRI, VIMC, VIPS, VMC Downgrades: BT, HZNP, SGOC, SUNS, SWS, WSBF Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

3 Stocks Rising on Unusual Volume

3 Stocks Rising on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Why Horizon Pharma (HZNP) Is Up Today

Why Horizon Pharma (HZNP) Is Up Today

Horizon Pharma HZNP was up Wednesday afternoon on the news that it had acquired Vidara Therapuetics in a reverse merger valued at $660 million in cash and stock. The new company will be called Horizon Pharma plc.

2 Big Stocks on Traders' Radars

2 Big Stocks on Traders' Radars

Here's how to trade some of the most active stocks on the market today.

Horizon Pharma (HZNP) Hits New Lifetime High Today

Horizon Pharma (HZNP) Hits New Lifetime High Today

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

3 Stocks Triggering Breakouts on Unusual Volume

3 Stocks Triggering Breakouts on Unusual Volume

These stocks rising on unusual volume are within range of triggering breakout trades.

'Mad Money' Lightning Round: I Want to Buy Time Warner

'Mad Money' Lightning Round: I Want to Buy Time Warner

Cramer likes ChannelAdvisor and Exelixis but is staying away from Universal Display and Yandex.

Jim Cramer's 'Mad Money' Recap: Us vs. Them

Jim Cramer's 'Mad Money' Recap: Us vs. Them

The markets are turning into Russia and China against the rest of the world, Cramer warns.

New Lifetime High Today: Horizon Pharma (HZNP)

New Lifetime High Today: Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

Horizon Pharma Inc Stock Upgraded (HZNP)

Horizon Pharma Inc Stock Upgraded (HZNP)

Horizon Pharma (Nasdaq:HZNP) has been upgraded by TheStreet Ratings from a sell to hold.

Ratings Changes Today

Upgrades: AU, HCCI, HZNP, IKNX, NPD, SJT Downgrades: ABR, COH, CRESY, IAG, PPP, RIG, WRE, YNDX Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Yellen Testimony Could Move the Markets

Watch for any comments Tuesday that depart from the status quo or offer encouragement in the face of weak economic data.

Why Horizon Pharma (HZNP) Is Up Today

Why Horizon Pharma (HZNP) Is Up Today

Horizon Pharma (HZNP) rises after the company announced its preliminary results for the fourth quarter and fiscal year 2013. The company expects total net revenues to be between $31.9 million and $32.4 million for the fourth quarter and between $79.5 million and $80 million for the fiscal year. The company also provided an update on the status of its osteoarthritis drug VIMOVO and announced that all required FDA transfers, including the New Drug Application (NDA) and Investigational New Drug (IND), have been completed. Furthermore, Horizon-labeled inventory "has been manufactured, shipped and sold into the wholesale and pharmacy channel," according to the company's statement.

New Lifetime High Reached By Horizon Pharma (HZNP)

New Lifetime High Reached By Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

4 Biotech Stocks Under $10 Making Big Moves

4 Biotech Stocks Under $10 Making Big Moves

Keep these under-$10 biotech stocks on your radar.

A Classic Melt-Up

Hopeful bears were dead wrong again.

A Very Shallow Pullback

Conditions still favor the bulls.

5 Stocks With Big Insider Buying

5 Stocks With Big Insider Buying

Insiders at these companies have been scooping up shares of their own stocks lately.

Top Insider Trades: VRX HZNP SEAS LNBB

Top Insider Trades: VRX HZNP SEAS LNBB

The top 10 open-market insider purchases and sales filed at the SEC Tuesday.

Horizon Pharma (HZNP) In A Perilous Reversal

Horizon Pharma (HZNP) In A Perilous Reversal

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate

5 Stocks With Big Insider Buying

5 Stocks With Big Insider Buying

Insiders at these companies have been scooping up shares of their own stock lately.

The Slow-Motion Rally Rolls On

Even if you are a raging bull, it is still tricky to navigate this market.

'Mad Money' Lightning Round: F5 Networks Is a Great Stock

'Mad Money' Lightning Round: F5 Networks Is a Great Stock

Halcon Resources is a big disappointment, Cramer says, but he's ready to buy Cimarex Energy.

Jim Cramer's 'Mad Money' Recap: Forget the Fed's Old News

Jim Cramer's 'Mad Money' Recap: Forget the Fed's Old News

What the Fed was thinking over a month ago has no lasting impact on today's markets, Cramer says.

Stock To Watch: Horizon Pharma (HZNP) In Perilous Reversal

Stock To Watch: Horizon Pharma (HZNP) In Perilous Reversal

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate

At a Loss

The major indices are out of step with the underlying action.

First Week Of May 2014 Options Trading For Horizon Pharma (HZNP)

First Week Of May 2014 Options Trading For Horizon Pharma (HZNP)

Investors in Horizon Pharma Inc saw new options become available this week, for the May 2014 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 232 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week Of HZNP September 21st Options Trading

First Week Of HZNP September 21st Options Trading

Investors in Horizon Pharma Inc saw new options begin trading this week, for the September 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the HZNP options chain for the new September 21st contracts and identified the following put contract of particular interest.

TheStreet Quant Rating: C+ (Hold)